Literature DB >> 15320503

Immunomodulatory activity of boswellic acids of Boswellia serrata Roxb.

Pratibha Pungle1, M Banavalikar, A Suthar, M Biyani, S Mengi.   

Abstract

Extract of gum resin of B. serrata containing 60% acetyl 11-keto beta boswellic acid (AKBA) along with other constituents such as 11-keto beta-boswellic acid (KBA), acetyl beta-boswellic acid and beta-boswellic acid has been evaluated for antianaphylactic and mast cell stabilizing activity using passive paw anaphylaxis and compound 48/80 induced degranulation of mast cell methods. The extract inhibited the passive paw anaphylaxis reaction in rats in dose-dependant manner (20, 40 and 80 mg/kg, po). However, the standard dexamethasone (0.27 mg/kg, po) revealed maximum inhibition of edema as compared to the extract. A significant inhibition in the compound 48/80 induced degranulation of mast cells in dose-dependant manner (20, 40 and 80 mg/kg, po) was observed thus showing mast cell stabilizing activity. The standard disodium cromoglycate (50 mg/kg, ip) was found to demonstrate maximum per cent protection against degranulation as compared to the extract containing 60% AKBA. The results suggest promising antianaphylactic and mast cell stabilizing activity of the extract.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15320503

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  11 in total

1.  Co-administration of 3-Acetyl-11-Keto-Beta-Boswellic Acid Potentiates the Protective Effect of Celecoxib in Lipopolysaccharide-Induced Cognitive Impairment in Mice: Possible Implication of Anti-inflammatory and Antiglutamatergic Pathways.

Authors:  Aya Shoukry Sayed; Nesrine Salah El Dine El Sayed
Journal:  J Mol Neurosci       Date:  2016-03-16       Impact factor: 3.444

Review 2.  Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data.

Authors:  Mona Abdel-Tawab; Oliver Werz; Manfred Schubert-Zsilavecz
Journal:  Clin Pharmacokinet       Date:  2011-06       Impact factor: 6.447

3.  Boswellic acid blocks signal transducers and activators of transcription 3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1.

Authors:  Ajaikumar B Kunnumakkara; Asha S Nair; Bokyung Sung; Manoj K Pandey; Bharat B Aggarwal
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

4.  Natural anti-inflammatory agents for pain relief.

Authors:  Joseph C Maroon; Jeffrey W Bost; Adara Maroon
Journal:  Surg Neurol Int       Date:  2010-12-13

5.  Medicinal plants with potential anti-arthritic activity.

Authors:  Manjusha Choudhary; Vipin Kumar; Hitesh Malhotra; Surender Singh
Journal:  J Intercult Ethnopharmacol       Date:  2015-03-14

6.  Phenotypic Investigation of the Antimicrobial Effect of Organic and Hydro-Alcoholic Extracts of Boswellia serrata on Oral Microbiota.

Authors:  Sedigheh Bakhtiari; Fatemeh Nematzade; Mojdeh Hakemi-Vala; Ghazaleh Talebi
Journal:  Front Dent       Date:  2019-10-15

7.  Cardiac arrest and stroke due to unsupervised use of herbal preparation.

Authors:  Malak A Alshammari; Ali Hassan; Amna S Alsaihati; Faisal H Aldera; Haitham S Alaithan
Journal:  J Family Community Med       Date:  2020-01-13

8.  A randomized and comparative study to assess safety and efficacy of supplemental treatment of a herbal formulation - Aayudh Advance comprising essential oils in patients with corona virus 2019 (COVID-19).

Authors:  Jayesh Dutt; Bhavdeep Ganatra; Nilay Suthar; Mohammedebrahim Malek; Bhakti Shukla; Krupali Shukla; Karna Shukla; Shreya Pandit; Manish Rachchh; Rina Gokani; Mona Bhalani
Journal:  Contemp Clin Trials Commun       Date:  2021-03-11

Review 9.  Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly.

Authors:  Adel A Gomaa; Hamdy S Mohamed; Rasha Bakheet Abd-Ellatief; Mohamed A Gomaa
Journal:  Inflammopharmacology       Date:  2021-07-05       Impact factor: 4.473

10.  Current status of herbal drugs in India: an overview.

Authors:  Ashok D B Vaidya; Thomas P A Devasagayam
Journal:  J Clin Biochem Nutr       Date:  2007-07       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.